Get startedLog in
    Picture of Alpine Immune Sciences logo

    ALPN — Alpine Immune Sciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Alpine Immune Sciences Inc - ALPN-303 Well-Tolerated In Phase 1 Healthy Volunteer Study With On-Target Effects On Key Biomarkers

    Picture of Alpine Immune Sciences logoAlpine Immune Sciences
    12/09/2022 22:30
    Sept 12 (Reuters) - Alpine Immune Sciences Inc  ALPN.O :
    * ALPINE IMMUNE SCIENCES INC - ALPN-303 WELL-TOLERATED IN
PHASE 1
HEALTHY VOLUNTEER STUDY WITH ON-TARGET EFFECTS ON KEY BIOMARKERS

Source text for Eikon:  ID:nBw4NfK98a 
Further company coverage:  ALPN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Alpine Immune Sciences

    See all news